Drug Shortage Report for APO-SUCRALFATE - TAB 1G
| Report ID | 169045 |
| Drug Identification Number | 02125250 |
| Brand name | APO-SUCRALFATE - TAB 1G |
| Common or Proper name | SUCRALFATE |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SUCRALFATE |
| Strength(s) | 1G |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 BTL |
| ATC code | A02BX |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-09-06 |
| Estimated end date | 2023-09-22 |
| Actual end date | 2023-09-15 |
| Shortage status | Resolved |
| Updated date | 2023-09-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v40 | 2023-09-22 | French | Compare |
| v39 | 2023-09-22 | English | Compare |
| v38 | 2023-09-15 | French | Compare |
| v37 | 2023-09-15 | English | Compare |
| v36 | 2023-09-01 | French | Compare |
| v35 | 2023-09-01 | English | Compare |
| v34 | 2023-08-23 | French | Compare |
| v33 | 2023-08-23 | English | Compare |
| v32 | 2023-07-13 | French | Compare |
| v31 | 2023-07-13 | English | Compare |
| v30 | 2023-06-16 | French | Compare |
| v29 | 2023-06-16 | English | Compare |
| v28 | 2023-06-09 | French | Compare |
| v27 | 2023-06-09 | English | Compare |
| v26 | 2023-05-12 | French | Compare |
| v25 | 2023-05-12 | English | Compare |
| v24 | 2023-04-21 | French | Compare |
| v23 | 2023-04-21 | English | Compare |
| v22 | 2023-03-23 | French | Compare |
| v21 | 2023-03-23 | English | Compare |